SCHEMBL5657441

SCHEMBL5657441

COc1ccc(Cc2cc3c(C=O)cc(OC)c(OC)c3o2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 5/20 0.43
TUBB4A P04350 4/20 0.43
TUBB P07437 4/20 0.43
TUBA3C P0DPH7 4/20 0.43
TUBA1B P68363 4/20 0.43
TUBA4A P68366 4/20 0.43
TUBB4B P68371 4/20 0.43
TUBB3 Q13509 4/20 0.43
TUBB2A Q13885 4/20 0.43
TUBB8 Q3ZCM7 4/20 0.43
TUBA3E Q6PEY2 4/20 0.43
TUBA1A Q71U36 4/20 0.43
TUBA1C Q9BQE3 4/20 0.43
TUBB6 Q9BUF5 4/20 0.43
TUBB2B Q9BVA1 4/20 0.43
CNR2 P34972 1/20 0.42
ALDH1A1 P00352 2/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5660910 0.89 GPR55 (0.46) TUBB1CNR2ALDH1A1CA12CA1
SCHEMBL5659475 0.89 ALDH1A1 (0.48) TUBB1CNR2ALDH1A1CA12CA1
SCHEMBL5660258 0.89 TUBB1 (0.43) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5657738 0.87 ALDH1A1 (0.42) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5657121 0.81 MEN1 (0.43) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5659220 0.81 TUBB4A (0.43) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5656339 0.79 LMNA (0.43) TUBB1ALDH1A1CA12CA1CA2
SCHEMBL5657689 0.77 CA12 (0.38) TUBB1ALDH1A1CA12CA1CA2
SCHEMBL5659514 0.75 PTGS1 (0.37) TUBB1ALDH1A1CA12CA1CA2
SCHEMBL5657302 0.74 TUBB1 (0.38) TUBB1TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR TUBB1 1060/4885TUBB4A 1040/4885TUBB 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.